The page is the record's research on the issuer — no analyst, no rating, no view. # SANTEN PHARMACEUTICAL CO.,LTD. (Prime Market: 4536) — research page As of 2026-11-06 · jp-cm-kg · record version 1 ## Identity and listing The issuer is SANTEN PHARMACEUTICAL CO.,LTD., listed on the Prime Market under ticker 4536. Its ISIN is JP3336000009 and its LEI is 529900TPT3I7C17MIM03. Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical, and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted. ## The disclosure read The record holds 11 filings on 8 filing days in the window 2025-11-06 to 2026-11-06. The filings are 3 ad hoc, 2 corporate news, 1 prospectus, 3 regulatory filing and 2 results. The median gap between filing days is 31 days. The latest filing is dated 2026-10-27 and is of type ad hoc, which is 10 days before the record date of 2026-11-06, a latency of 10 days. The Prime Market median is 10 filings, a cadence gap of 29.0 days and a latency of 70.0 days, across 1557 issuers. The 3250 Pharmaceutical sector median is 8.0 filings, a cadence gap of 49.5 days and a latency of 85.0 days, across 80 issuers. The issuer's filings are above the exchange median in count and below it in cadence gap and latency; it is above the sector median in count and below it in cadence gap and latency. ## Auditor The auditor of record is 有限責任 あずさ監査法人, whose location is not on the record. Auditor changes are not on the record. ## Events and halts Listing, delisting, name change, domicile change and segment move are not on the record, as the index does not carry a lifecycle type for this market. The issuer is listed and not halted. ## Orderability For the client category Qualified Institutional Investors, the outcome is not determinable, because the rule states a product scope and the subject's record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04. ## Coverage The issuer's investor-relations page names 10 research houses: BofA Securities Japan Co., Ltd.; Citigroup Global Markets Japan Inc.; Daiwa Securities Co. Ltd.; Goldman Sachs Japan Co., Ltd.; JPMorgan Securities Japan Co., Ltd.; Mizuho Securities Co., Ltd.; Morgan Stanley MUFG Securities Co., Ltd.; SMBC Nikko Securities Inc.; Tokai Tokyo Intelligence Laboratory Co., Ltd.; and UBS AG. ## Open research No openly published research notes were found for the issuer. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The market's vintage is not sealed. No sealed years hold the issuer, no earliest sealed date is held for the market, and the live record began on a date not on the record. ## Sources 10 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange) - https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin) - https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4536 (the disclosure lines) - https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag) - https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YDH1 (the auditor) - https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter) - https://www.santen.com/en/ir/stock/analyst (coverage) - https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4536 (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/jp/TSE-PRIME/4536 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp